BioDueDiligence
$ALNY and $ARWR cross license agreement. Arrowhead can devel HBV RNAi drug and Alnylam gets access to new delivery tech http://t.co/qj6DkXjg
- About
- Help
- Blog
- Jobs
- Press
- Tools
- Mobile
- Developers
- House Rules
- For Public Companies
- For Market Professionals
-
- Terms
- Privacy
- Disclaimer
- Market Quotes provided by Xignite © 2013 StockTwits, Inc.